// App-Quantinova.ai

10029 : Six and Twelve-month Clinical and Imaging Results of the Multicenter First-in-man BIOSOLVE-I Study with the Paclitaxel-Eluting Bioabsorbable Magnesium Scaffold (DREAMS)

Researchers

Presenter

  • Stadtische Kliniken-Neuss

Principal Investigators

  • Raimund Erbel

  • Jacques Koolen

  • Paul Erne

  • Stefan Verheye

  • Paul Vermeersch

  • Hubertus Degen

  • Ron Waksman

  • Neil Weissman

  • Francesco Prati

Medical Centers

  • Luzerner Kantonsspital, Lucerne, Switzerland

  • ZNA Middelheim, Antwerp, Belgium

  • Rome Heart Research, Rome, Italy

  • ZNA Middelheim, Antwerp, Belgium

  • Catharina Ziekenhuis, Eindhoven, Netherlands

  • German Heart Center, Essen, Germany

  • MedStar Health, Washington, DC

  • Lukaskrankenhaus GmbH Neuss, Neuss, Germany

Locations

  • Italy

  • Netherlands

  • Germany

  • Switzerland

  • United States

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • Twist-related protein 2

Drug/Treatment

  • Paclitaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved